Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer by Yuxin Mu, Yanchun Meng, Yiqun Du, Xiaojun Liu, Jian Zhang

Get full text

MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells by Yiqun Du, Jian Zhang, Yanchun Meng, Mingzhu Huang, Wangjun Yan, Zhiqiang Wu

Get full text

Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis by Xiaowen Ge, Yiqun Du, Yiqun Du, Jianfeng Chen, Na Zhu, Jiamei Yao, Xin Zhang, Xin Zhang, Na Wang, Na Wang, Yujing Sun, Yujing Sun, Feng Gao, Weiguo Hu, Weiguo Hu, Yingyong Hou

Get full text

Preclinical and clinical activity of DZD1516, a full blood–brain barrier-penetrant, highly selective HER2 inhibitor by Jian Zhang, Nicholas P. McAndrew, Xiaojia Wang, Yiqun Du, Brian DiCarlo, Mei Wang, Kan Chen, Wenlei Yu, Xichun Hu

Get full text